Betulinic acid inhibits LPS-induced MMP-9 expression by suppressing NF-kB activation in BV2 microglial cells

Biomolecules and Therapeutics

Volumn 19, Issue 4, 2011, Pages 431-437

  Lee, J W ^a   Choi, Y J ^a   Kim, S I ^a   Lee, S Y ^a   Kang, S S ^a   Kim, N H ^a   Kwon, Y S ^a   Lee, H J ^a   Chun, W ^a   Kim, S S ^a  

^a Kangwon National University   (South Korea)

Author keywords

Betulinic acid; BV2 microglial cells; Cytokines; Lipopolysaccharide; MMP 9; NF kB

Indexed keywords

BETULIC ACID; GELATINASE B; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; DRUG MECHANISM; ENZYME ACTIVITY; MICROGLIA; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

EID: 81255195460     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2011.19.4.431     Document Type: Article

References (38)

1. Aquilano, K., Baldelli, S., Rotilio, G. and Ciriolo, M. R. (2008) Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols. Neurochem. Res. 33, 2416-2426.
2. Bonizzi, G. and Karin, M. (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.
3. Chao, C. C. (1992) Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J. Infect Dis. 166, 847-853.
4. Chintharlapalli, S., Papineni, S., Ramaiah, S. K. and Safe, S. (2007) Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 67, 2816-2823.
5. Cho, I. H., Hong, J., Suh, E. C., Kim, J. H., Lee, H., Lee, J. E., Lee, S., Kim, C. H., Kim, D. W., Jo, E. K., Lee, K. E., Karin, M. and Lee, S. J. (2008) Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death. Brain 131, 3019-3033.
6. Choi, M. S., Cho, K. S. and Shin, S. M. (2010) ATP induced microglial cell migration through non-transcriptional activation of matrix metalloproteinase- 9. Arch. Pharm. Res. 33, 257-265.
7. Cuzner, M. L. and Opdenakker, G. (1999) Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 94, 1-14.
8. Do, J. C., Chai, J. Y. and Son, K. H. (1991) Studies on the components of Lycopus lucidus (I). Kor. J. Pharacogn. 22, 162-165.
9. Fujioka, T., Kashiwada, Y., Kilkuskie, R. E., Cosentino, L. M., Ballas, L. M., Jiang, J. B., Janzen, W. P., Chen, I. S. and Lee, K. H. (1994) Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J. Nat. Prod. 57, 243-247.
10. Fulda, S. (2008) Betulinic Acid for cancer treatment and prevention. Int. J. Mol. Sci. 9, 1096-1107.
11. Ghosh, S., May, M. J. and Kopp, E. B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
12. Graber, M. B. and Streit, W. J. (2010) Microglia: biology and pathology. Acta. Neuropathol 119, 89-105.
13. Hailer, N. P. (2008) Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog. Neurobiol. 84, 211-233.
14. Hashioka, S., McGeer, P. L., Monji, A. and Kanba, S. (2009) Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease. Cent. Nerv. Syst. Agents Med. Chem. 9, 12-19.
15. Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S. and Selkoe, D. (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24, 173-182.
16. Kappert, K., Meyborg, H., Clemenz, M., Graf, K., Fleck, E., Kintscher, U. and Stawowy, P. (2008) Insulin facilitates monocyte migration: a possible link to tissue inflammation in insulin-resistance. Biochem. Biophys. Res. Commun. 365, 503-508.
17. Karin, M., Takahashi, T., Kapahi, P., Delhase, M., Chen, Y., Makris, C., Rothwarf, D., Baud, V., Natoli, G., Guido, F. and Li, N. (2001) Oxidative stress and gene expression: the AP-1 and NF-kappaB connections. Biofactors 15, 87-89.
18. Kato, H. and Walz, W. (2000) The initiation of the microglial response. Brain Pathol. 10, 137-143.
19. Kreutzberg, G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
20. Lee, J. W., Cheong, I. Y. and Kim, H. S. (2011) Anti-inflammatory Activity of 1-docosanoyl Cafferate Isolated from Rhus verniciflua inLPS-stimulated BV2 Microglial Cells. Korean J. Physiol. Pharmacol. 15, 9-15.
21. Li, Q., Park, P. W., Wilson, C. L. and Parks, W. C. (2002) Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111, 635-646.
22. Li, Q. and Verma, I. M. (2002) NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734.
23. Lu, Q., Xia, N. and Xu, H. (2011) Betulinic acid protects against cerebral ischemia-reperfusion injury in mice by reducing oxidative and nitrosative stress. Nitric. Oxide. 30;24(3), 132-138.
24. Matsumoto, H. (1992) [Some markers reflecting the pathology and disease activity of multiple sclerosis]. No To Shinkei 44, 95-102.
25. McGeer, P. L. and McGeer, E. G. (1998) Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis. Assoc. Disord. 12(Suppl 2), S1-6.
26. McQuibban, G. A., Gong, J. H., Tam, E. M., McCulloch, C. A., Clark- Lewis, I. and Overall, C. M. (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206.
27. Merrill, J. E. and Benveniste, E. N. (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19, 331-338.
28. Merrill, J. E. and Chen, I. S. (1991) HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 5, 2391- 2397. Patra, A., Chaudhuri, K. S. and Panda, K. S. (1988) Betulun-3-cafferate from Quercus suber 13C-NMNR spectra of some lupense. J. Nat. Prod. 51, 217-220.
29. Perry, V. H. and Gordon, S. (1988) Macrophages and microglia in the nervous system. Trends Neurosci. 11, 273-277.
30. Ray, B. and Lahiri, D. K. (2009) Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin. Curr. Opin. Pharmacol. 9, 434-444.
31. Recio, M. C., Giner, R. M., Manez, S., Gueho, J., Julien, H. R., Hostettmann, K. and Rios, J. L. (1995) Investigations on the steroidal antiinflammatory activity of triterpenoids from Diospyros leucomelas. Planta. Med. 61, 9-12.
32. Sellebjerg, F. and Sorensen, T. L. (2003) Chemokines and matrix metalloproteinase- 9 in leukocyte recruitment to the central nervous system. Brain Res. Bull. 61, 347-355.
33. Soler, F., Poujade, C., Evers, M., Carry, J. C., Henin, Y., Bousseau, A., Huet, T., Pauwels, R., De Clercq, E., Mayaux, J. F., Le Pecq, J. B. and Dereu, N. (1996) Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. J. Med. Chem. 39, 1069-1083.
34. Tuttolomondo, A., Di Raimondo, D., di Sciacca, R., Pinto, A. and Licata, G. (2008) Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des. 14, 3574-3589.
35. Woo, M. S., Park, J. S., Choi, I. Y., Kim, W. K. and Kim, H. S. (2008) Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia. J. Neurochem. 106, 770-780.
36. Yogeeswari, P. and Sriram, D. (2005) Betulinic acid and its derivatives: a review on their biological properties. Curr. Med. Chem. 12, 657- 666.
37. Yong, V. W., Krekoski, C. A., Forsyth, P. A., Bell, R. and Edwards, D. R. (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21, 75-80.
38. Zuo, J., Ferguson, T. A., Hernandez, Y. J., Stetler-Stevenson, W. G. and Muir, D. (1998) Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J. Neurosci. 18, 5203-5211.